Loading page…

TCM Ltd (TCMLMTD) · mywealthgrid

About

TCM Ltd operates in Commodity Chemicals within the Materials sector.

Face value: ₹10

Market cap

₹36 Cr

P/E

—

P/B

1.5×

Dividend yield

ROE

-21%

ROCE

-13.2%

Debt / equity

0.9

OPM

-22.9%

EPS (TTM)

₹-7.8

Book value

₹33.0

52-week high

₹74.3

52-week low

₹37.2

₹48.0+6.7%1Y

Beta

0.8

Damps index moves

Volatility (1y)

63.8%

Annualised, daily returns

RSI (14)

52.5

Neither overbought nor oversold

Rel. strength (1y)

-0.5%

Behind the market

Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.

Quick read

rule-based

Pros

No positive flags triggered.

Cons

−Low return on equity of -7.4% (3-yr avg)
−Revenue shrank over the last 5 years (-66.5% a year)
−Weak interest coverage of -2.1×

Research score

Structured signal from quality, growth, valuation and momentum.

63/100

Business quality: 11
Growth: 100
Valuation: 98
Momentum

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Deepak Fertilizers And Petrochemicals Corporation LimitedDEEPAKFERTDEEPAKFERT	₹16,417 Cr	₹21,903 Cr	₹12,104 Cr	₹2,016 Cr	14.6%	₹984 Cr	6.4%	12.6%	11.3%	55
Tata Chemicals LimitedTATACHEMTATACHEM	₹15,487 Cr	₹23,488 Cr	₹15,120 Cr	₹1,711 Cr	12.4%	₹-2,165 Cr	-11.8%	2.9%	-8.9%	113
Gujarat Narmada Valley Fertilizers And Chemicals LimitedGNFCGNFC	₹8,655 Cr	₹8,655 Cr	₹8,410 Cr	₹1,241 Cr	11.3%	₹1,037 Cr	10.4%	10.6%	9.1%	81
TANFAC Industries LtdTANFACINDTANFACIND	₹6,909 Cr	₹7,002 Cr	₹711 Cr	₹112 Cr	15.8%	₹70 Cr	9.9%	27.7%	20.5%	112
Gujarat Alkalies And Chemicals LimitedGUJALKALIGUJALKALI	₹4,430 Cr	₹4,998 Cr	₹4,498 Cr	₹510 Cr	9.3%	₹66 Cr	-0.1%	1.6%	-0%	25
Grauer & Weil India LimitedGRAUWEILGRAUWEIL	₹3,709 Cr	₹3,717 Cr	₹1,134 Cr	₹188 Cr	16.6%	₹69 Cr	13.9%	23%	18%	72
Ghcl LimitedGHCLGHCL	₹3,700 Cr	₹3,762 Cr	₹3,064 Cr	₹689 Cr	22.5%	₹472 Cr	15.4%	17%	13.4%	126
J.g.chemicals LimitedJGCHEMJGCHEM	₹2,392 Cr	₹2,399 Cr	₹1,071 Cr	₹96 Cr	8.4%	₹75 Cr	7.1%	18.2%	13.3%	101
Thirumalai Chemicals LimitedTIRUMALCHMTIRUMALCHM	₹1,764 Cr	₹3,857 Cr	₹1,832 Cr	₹20 Cr	-2%	₹-152 Cr	-9.7%	-3.3%	-12.3%	14
Ig Petrochemicals LimitedIGPLIGPL	₹1,754 Cr	₹2,110 Cr	₹2,073 Cr	₹207 Cr	4.9%	₹82 Cr	0.1%	3.2%	0.2%	23
Indo Borax & Chemicals LimitedINDOBORAXINDOBORAX	₹1,507 Cr	₹1,507 Cr	₹232 Cr	₹52 Cr	20.5%	₹56 Cr	23.3%	15.5%	15.1%	110
Innovassynth Technologies (India) LtdINOVSYNTHINOVSYNTH	₹1,462 Cr	₹1,466 Cr	₹0 Cr	₹-0 Cr	—	₹-5 Cr	—	-1.1%	-12%	—

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	4,703	4,694	7	32	26	20
COGS	3,436	2,859	6	23	18	14
Gross profit	1,267	1,835	2	9	8	5
	709	1,200	5	11	10	10
	558	634	-4	-2	-2	-5
OPM %	11.9%	13.5%	-49.9%	-7%	-8.3%	-22.9%
Depreciation	79	81	0	0	0	1
Interest	52	55	0	0	1	2
	31	15	0	0	4	1
Profit before tax	460	574	-4	-2	1	-6
Tax	165	150	-0	0	-0	-0
Tax %	35.9%	26.1%	-0.5%	1.8%	-2.2%	-0.7%
	295	424	-4	-2	1	-6
PAT margin %	6.3%	9%	-58.1%	-7.1%	5.4%	-30.3%
EPS (₹)	—	—	-6	-2.6	2.2	-7.8
EPS adjusted (₹)	121.8	175.4	-5.7	-2.6	2.2	-7.8
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	3	24	24	7	7	7	7
Reserves	29	1,532	1,889	23	21	23	17
	5	977	1,560	1	0	11	22
	31	1,087	825	37	55	35	36
Total equity & liabilities	69	3,620	4,297	69	84	76	83
	58	1,061	1,065	36	17	9	9
CWIP	—	22	257	—	—	—	0
Investments	0	158	206	0	0	5	8
	11	2,379	2,770	33	67	62	66
Total assets	69	3,620	4,297	69	84	76	83

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	26.9%	39.1%	21.1%	27.9%	30.1%	27.7%
EBITDA margin %	11.9%	13.5%	-49.9%	-7%	-8.3%	-22.9%
EBIT margin %	10.2%	11.8%	-55%	-7.9%	-9.7%	-25.7%
PAT margin %	6.3%	9%	-58.1%	-7.1%	5.4%	-30.3%
Working capital
Receivable days	16	21	233	96	95	115
Inventory days	184	260	239	480	571	683
Payable days	66	45	81	44	50	44
NWC days	134	236	390	532	616	755
Leverage
Current ratio	1.42	1.36	0.5	1.8	0.9	0.88
Debt to EBITDA	1.75	2.46	—	—	—	—
Debt to equity	0.63	0.82	0.05	0.01	0.37	0.9
Interest coverage	9.9	10.6	-14.9	-15.1	3.3	-2.1
Asset turnover	1.3	1.09	0.11	0.38	0.34	0.24
Return ratios
Return on assets %	8.1%	9.9%	-6.2%	-2.7%	1.8%	-7.3%
Return on capital employed %	24.6%	25.7%	-0.3%	-4.3%	5.1%	-13.2%
Return on equity %	18.9%	22.2%	-13.9%	-8%	4.6%	-24.3%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	7.71%	7.71%	7.71%	7.44%	7.44%	7.44%	7.44%	7.44%	7.44%	7.44%	7.44%	7.44%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	42.78%	42.78%	42.78%	43.05%	43.05%	43.05%	43.05%	43.05%	43.05%	43.05%	43.05%	43.05%
No. of shareholders	—	—	—	—	—	—	—	—	4,564	4,272	4,198	4,160

Promoter holding up 0 percentage points since Sep 2023.

13 deals · 10 Jun 2022 – 19 May 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
19 May 2026	SHAH DIPAK KANAYALAL	Bulk	BSE	Buy	41,337	₹48.71	₹0.20 Cr
12 Nov 2025	JAI NARAYAN SINGH	Bulk	BSE	Sell	55,894	₹57.21	₹0.32 Cr
7 May 2024	ANAND OMPRAKASH AGRAWAL	Bulk	BSE	Buy	37,934	₹59.76	₹0.23 Cr
5 Dec 2023	LEELAMMATHENUMKALJOSEPH	Bulk	BSE	Buy	53,922	₹42.27	₹0.23 Cr
5 Dec 2023	LEELAMMATHENUMKALJOSEPH	Bulk	BSE	Sell	4,000	₹45.80	₹0.02 Cr
29 Nov 2023	MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	BSE	Sell	73,030	₹56.28	₹0.41 Cr
29 Nov 2023	MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	BSE	Buy	44,000	₹53.23	₹0.23 Cr
24 Nov 2023	MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	BSE	Buy	45,000	₹51.05	₹0.23 Cr
23 Aug 2023	DHWAJA SHARES & SECURITIES PVT LTD	Bulk	BSE	Sell	60,000	₹40.00	₹0.24 Cr
25 Jul 2022	KIFS ENTERPRISE	Bulk	BSE	Buy	50,000	₹52.75	₹0.26 Cr

1–10 of 13

1 / 2

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. JOSEPH VARGHESEExecutive Director-MD
Mr. GEORGE VARGHESENon-Executive - Non Independent Director
Mrs. RANI JOSENon-Executive - Non Independent Director
M P MohananChief Financial Officer
Mr. RAMESH BABUExecutive Director
Mr. JOSE JACOBNon-Executive - Independent Director
Mr. MAHESH GOPALAKRISHNANNon-Executive - Independent Director
Mr. SREENIVASA SADANANDA BHATNon-Executive - Independent Director
Mr. BOBBY JOHNNon-Executive - Independent Director
Gokul V ShenoyCompany Secretary and Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in TCM Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results13 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

41 announcementsExport CSV

31 Dec 2025, 6:43 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

13 Nov 2025, 12:15 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

11 Nov 2025, 12:12 pmBoard Meeting

Board Meeting Outcome for And The Consolidated And Standalone Unaudited Financial Results Along With The Consolidated And Standalone Limited Review Reports For The Quarter Ended 30Th September 2025

Outcome of Board Meeting PDF

10 Nov 2025, 12:33 pmCompany Update

Intimation Under Regulation 30 Of The SEBI(LODR) Regulations 2015 For Opening Of The Healthcare Division Office Of The Company

General PDF

29 Oct 2025, 2:18 pmBoard Meeting

Board Meeting Intimation for Consideration And Approval Of The Consolidated And Standalone Unaudited Financial Results For The Quarter Ended 30Th September 2025

Exchange filing PDF

14 Oct 2025, 3:11 pmCompany Update

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 PDF

29 Sept 2025, 4:17 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

27 Sept 2025, 5:01 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

Date	Category	Subject	Filing
31 Dec 2025, 6:43 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
13 Nov 2025, 12:15 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication

Loading announcements…

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	791	-173	-11	2	-10	-5
	-108	-257	6	-1	-0	-4
	-704	442	5	-1	10	9
Net cash flow	-21	12	-0	0	0	0
Free cash flow	702	-467	-13	1	-11	-6
CFO / Operating profit %	141.7%	-27.3%	—	—	—	—

TCM Ltd

TCM Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

1

Announcements

Not in the F&O segment

No fund holdings on record

1

Announcements

Annual reports

Compounded sales growth

Stock price CAGR

Return on equity

TCM Ltd

TCM Ltd

About

Risk & technicals

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Board meetings1

Announcements

Not in the F&O segment

No fund holdings on record

Ratio timeline

Quarterly record

Bulk & block deals

Board and management

Board meetings1

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Stock price CAGR

Return on equity

1

1